Lipid regulating compositions
AssigneeWarner-Lambert Company
InventorBrian R. Krause
Life of this patent
Estimating the term…
Abstract
Single dose formulations containing a combination of a lipid regulating agent selected from gemfibrozil, clofibrate, bezafibrate, or fenofibrate and an ACAT inhibiting agent are effective pharmacological formulations for regulating blood serum lipid and cholesterol levels.
Claims2
A pharmaceutical composition comprising a lipid regulating effective amount of 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid or a lower alkyl ester or pharmaceutically acceptable acid addition salt thereof, together with an ACAT inhibitory effective amount of (Z)-N-(2,4,6-trimethoxyphenyl)-9-octadecenamide, together with a pharmaceutically acceptable carrier;
- wherein the lipid regulating compound and the ACAT inhibitory compound are present in a weight ratio of 1:1.
A pharmaceutical composition comprising a lipid regulating effective amount of 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid) or a lower alkyl ester or pharmaceutically acceptable acid addition salt thereof together with an ACAT inhibitory effective amount of (Z)-N-(2,4,6-trimethoxyphenyl)-9-octadecenamide, together with a pharmaceutically acceptable carrier;
- wherein the lipid regulating compound and the ACAT inhibitory compound are present in a weight ratio of 1:1.
Dependencies are inferred from the claim text.